Kurz gefasst
Fachartikel in der Zeitschrift Revista Ocronos, 2026.
Abstract (Originalsprache)
Sa 1282. 7. Wagner J, Glas J, Seiderer J, et al. Variants in the PTPN2 are associated with susceptibility to both Crohn’s disease and ulcerative colitis in the German population. Sesión de carteles presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abstract Sa 1291. 8. Mathieu N, Dumestre-Perard C, Kheav VD, et al. ASCA/OMPC are serological markers of Crohn’s disease disability and prognosis. Sesión de carteles presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abstract Mo 1979. 9. Ye M, Haffeman-Udagawa S, Liu L, et al. Distinctive diagnostic and prognostic value of antiglycan antibodies as serological IBD biomarkers in African American population. Sesión de carteles presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abstract Mo 1974. 10. Mahler M, Seaman A, Bogdanos DP, et al. Pr3-ANCA in inlammatory bowel disease: a useful marker to differentiate ulcerative colitis and Crohn’s disease? Sesión de carteles presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abstract Mo 1985. 11. Truta B, Li D, Mahadevan U, et al. Use of serological markers to predict Crohn’s diasease after ileal pouch anal anastomosis in patients diagnosed with ulcerative colitis at the time of operation. Sesión de carteles presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abstract Mo 1983. 12. Jensen MD, Kjeldsen JJ, Nathan T. Fecal calprotectin is equally sensitive in isolated colonic or small bowel Crohn’s disease. Sesión de carteles presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abstract Mo 1975. R ev G asroen trol M x, Vol. 7 6 , S u p l. 1 , 2 0 1 1 Yamamoto-Furusho JK. 79 13. Yamamoto-Furusho JK, Mendivil-Rangel EJ, Fonseca-Camarillo GC, et al. Differential expression of disc large homologue 5 (DLG5) and carnitine organization transporter (OCTN) genes in patients with ulcerative colitis. Sesión de carteles presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abstract Su 1174. 14. Horst SN, Swartz DA, Beaulieu DB, et al. A pilot study exploring the utility of gene expression proiling to differentiate Crohn’s diasease from ulcerative colitis and IBD from irritable bowel syndrome in patients with chronic diarrhea. Sesión de carteles presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Mo 1978. 15. Craig OF, O’Neill SB, Leong S, et al. A prospective trial of low dose computerized tomography (CT) with iterative reconstruction vs. conventional CT in Crohn’s disease. Sesión de trabajos orales AGA Research Forum presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abstract 340. 16. Fiorino G, Bonifacio C, Padrenostro N, et al. A prospective comparison between 1.5t magnetic resonance and 3t magnetic resonance in ileocolonic Crohn’s disease: a single center experience. Sesión de carteles presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abstract Mo 1994. 17. Hyun SB, Naganuma M, Nagahori M, et al. MR enterocolonography demonstrates comparative ability to endoscopy for the simultaneous assessment for small and large intestinal lesions in Crohn’s disease. Sesión de trabajos orales AGA Research Forum presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abstract 339. 18. Sandborn WJ, Travis S, Danese S, et al. Budesonide MMx for induction of remission of mild to moderate ulcerative colitis: data from a multicenter, randomized, double-blind, placebo-controlled study in Europe, Russia, Israel and Australia. Sesión de trabajos orales AGA Topic Forum presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abstract 292. 19. Sandborn WJ, Travis S, Moro L, et al. Budesonide MMx for induction of remission of mild to moderate ulcerative colitis: data from a multicenter, randomized, double-blind, placebo-controlled study in North America and India. Sesión de trabajos orales AGA Research Forum presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abstract 746. 20. Herrera de Guise C, Chavez-Ayala A, Yamamoto-Furusho JK. Factors associated with use of azathioprine in patients with ulcerative colitis. Sesión de carteles presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abstract Tu 1302. 21. Laharie D, Bourreille A, Branche J, et al. Cyclosporine versus inliximab in severe acute ulcerative colitis refractory to intravenous steroids: randomized trial. Sesión plenaria de la AGA presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abstract 619. 22. Pannacione R, Ghosh S, Middleton S, et al. Inliximab, azathioprine, inliximab + azathioprine for treatment of moderate to severe ulcerative colitis: The UC Success Trial. Sesión AGA Distinguished Abstract Plenary presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abstract 835. 23. Sandborn WJ, Van Assche GA, Reinisch W, et al. Induction and maintenance of clinical remission by adalimumab in patients with moderate to severe ulcerative colitis. Sesión de trabajos orales AGA Research Forum presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abstract 744. 24. Sandborn WJ, Gasink C, Gao LL, et al. A multicenter, randomized, doubleblind placebo-controlled phase 2b study of ustekinumab a human monoclonal antibody to IL12/IL23p40 in patients with moderately to severely active Crohn ś disease: results through week 22 from Certii trial. Sesión AGA Distinguished Abstract Plenary presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abstract 592. 25. Rutgeerts P, Fedorak RN, Hommes DW, et al. A phase 1 study of rHuMab Beta 7 in moderate to severe ulcerative colitis. Sesión de trabajos orales AGA Research Forum presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abstract 748. 26. Sandborn WJ, Ghosh S, Panes J, et al. Phase 2 study of CP-690,550, an oral janus kinase inhibitor in active ulcerative colitis. Sesión AGA Distinguished Abstract Plenary presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abs-Plenary presentada en DDW 2011; mayo 7-10; Chicago, IL, USA. Abs-
Zitieren
APA
(2026). Enfermedad inflamatoria intestinal. Revista Ocronos. https://doi.org/10.58842/yvuj1914
Vancouver
Enfermedad inflamatoria intestinal. Revista Ocronos. 2026. doi:10.58842/yvuj1914
BibTeX
@article{euvimed2026,
title = {Enfermedad inflamatoria intestinal},
journal = {Revista Ocronos},
year = {2026},
doi = {10.58842/yvuj1914}
}
EUVIMED